Pharmacokinetics of Telbivudine in Subjects with Various Degrees of Hepatic Impairment

This study evaluated the effect of hepatic impairment on the pharmacokinetics of telbivudine, an investigational nucleoside antiviral for the treatment of chronic hepatitis B virus infection. Twenty-four subjects were assigned to four hepatic function groups (normal function and mild, moderate, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhou, Xiao-Jian, Marbury, Thomas C., Alcorn, Harry W., Smith, William B., Dubuc Patrick, Gloria, Chao, George C., Brown, Nathaniel A.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2006
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1472205/
https://ncbi.nlm.nih.gov/pubmed/16641441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.50.5.1721-1726.2006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars